Revenue of Retrophin, Inc.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc (RE-034), a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
|YGYI Youngevity International, Inc.||NASDAQ > Consumer Services > Catalog/Specialty Distribution||-41.12|
|LOOP Loop Industries, Inc.||NASDAQ||-41.01|
|CDZI Cadiz, Inc.||NASDAQ > Public Utilities > Water Supply||-41.00|
|QRHC Quest Resource Holding Corporation.||NASDAQ > Technology > Diversified Commercial Services||-40.64|
|WTT Wireless Telecom Group, Inc.||NYSEMKT > Capital Goods > Electrical Products||-40.36|
|HZNP Horizon Pharma plc||NASDAQ > Health Care > Major Pharmaceuticals||-39.47|
|RTRX Retrophin, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-39.05|
|RDWR Radware Ltd.||NASDAQ > Miscellaneous > Business Services||908.53|
|NOW ServiceNow, Inc.||NYSE > Technology > Computer Software: Prepackaged Software||2,096.84|
|XTNT Xtant Medical Holdings, Inc.||NYSEMKT > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||2,385.30|
|FET Forum Energy Technologies, Inc.||NYSE > Energy > Metal Fabrications||8,053.25|
|CALD Callidus Software, Inc.||NASDAQ > Technology > EDP Services||14,180.27|
|TSLA Tesla, Inc.||NASDAQ > Capital Goods > Auto Manufacturing||16,068.78|